FDA Drug Inspections Post–Workforce Reductions: Potential Implications and Practical Steps Forward
The US Food and Drug Administration (FDA) is confronted with significant challenges in its inspection processes due to recent layoffs. Among other effects, the latest reduction in force of full-time ...
After a quiet January marked by administrative transition and internal upheaval at FDA, enforcement activity has accelerated sharply in 2025. No warning letters were issued in the first month of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback